Bio-Rad Laboratories, Inc. Q1 2026 earnings preview

Bio-Rad Laboratories, Inc. (BIO) is scheduled to announce Q1 earnings results on Thursday, April 30th, after market close.

dPCR Market to Surpass US$14.34 Billion by 2031, Propelled by Escalating Demand for High‑Precision Genetic Analysis - New Industry Research by The Insight Partners.

Growing demand for sensitive and accurate nucleic acid detection, wider use in clinical diagnostics and personalized medicine ...
MM&M

The Escalator: BridgeBio Oncology Therapeutics, Haleon, AstraZeneca and more

See which leaders are on the move across the pharma, biotech and medical marketing industries. JPMorgan Chase named Chris ...
Seeking Alpha

Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements

Feb 12, 2026, 7:35 PM ETBio-Rad Laboratories, Inc. (BIO) Stock, BIO.B StockAI-Generated Earnings Calls Insights ...

Global Clinical Diagnostics Market Projected to Reach USD 150.30 Billion by 2035 – SNS Insider

Rising chronic disease prevalence, AI-powered diagnostics, and growing demand for early detection drive consistent global market growth.Austin, United States, April 29, 2026 (GLOBE NEWSWIRE) -- ...